Myriad Genetics, Inc. announced the retirement of Jerry Lanchbury Ph.D. as chief scientific officer (CSO), after more than 19 years of distinguished service. Most recently, he drove health equity advancements such as Myriad's MyRisk™ Hereditary Cancer Test with RiskScore® for all ancestries.